Xconomy’s Digital Events →
Robert Gould talks being pitched about Epizyme: “it was a fundamental area of biology, a fundamental opportunity, particularly in the field of cancer.” He was named the company’s CEO in 2010.
Sponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.